(19)
(11) EP 4 569 003 A2

(12)

(88) Date of publication A3:
15.02.2024

(43) Date of publication:
18.06.2025 Bulletin 2025/25

(21) Application number: 23853320.2

(22) Date of filing: 09.08.2023
(51) International Patent Classification (IPC): 
C07K 16/30(2006.01)
A61K 39/395(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/28; C07K 2317/34; C07K 2317/92
(86) International application number:
PCT/US2023/029856
(87) International publication number:
WO 2024/035787 (15.02.2024 Gazette 2024/07)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 09.08.2022 US 202263396383 P

(71) Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Oakland, CA 94607-5200 (US)

(72) Inventors:
  • SLAMON, Dennis
    Los Angeles, CA 90095-7191 (US)
  • MCDERMOTT, Martina
    Los Angeles, CA 90095-7191 (US)
  • O'BRIEN, Neil, A.
    Los Angeles, CA 90095-7191 (US)
  • LIANG, Min
    Los Angeles, CA 90095-7191 (US)

(74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB 
Siebertstraße 3
81675 München
81675 München (DE)

   


(54) CLAUDIN-6 ANTIBODIES AND CONJUGATES THEREOF AND USES